Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AIG American International Group	$81.75 -0.9%	$83.88	$69.00 ▼ $88.07	$47.12B	0.63	4.36 million shs	3.32 million shs
CI Cigna Group	$302.71 -2.0%	$317.65	$262.03 ▼ $370.83	$80.86B	0.44	1.74 million shs	1.59 million shs
JNJ Johnson & Johnson	$156.87 -0.5%	$153.73	$140.68 ▼ $169.99	$377.44B	0.41	8.06 million shs	7.73 million shs
MRK Merck & Co., Inc.	$83.35 -0.8%	$79.07	$73.31 ▼ $129.93	$209.29B	0.39	13.39 million shs	9.22 million shs
NWSA News	$29.54 -0.4%	$28.41	$23.38 ▼ $30.69	$16.72B	1.23	2.93 million shs	1.79 million shs
PFE Pfizer	$25.65 -0.5%	$23.86	$20.92 ▼ $31.54	$145.83B	0.58	41.80 million shs	31.60 million shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AIG American International Group	-0.75%	-0.18%	-2.28%	+0.49%	+8.52%
CI Cigna Group	-0.32%	-3.44%	-1.71%	-6.39%	-6.47%
JNJ Johnson & Johnson	+1.05%	+1.16%	+0.81%	+4.02%	+5.56%
MRK Merck & Co., Inc.	+0.38%	+3.82%	+3.37%	+6.22%	-33.98%
NWSA News	+0.92%	+1.44%	+6.08%	+13.25%	+6.73%
PFE Pfizer	+0.81%	+1.27%	+6.06%	+17.72%	-9.11%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AIG American International Group	4.3523 of 5 stars	1.3	3.0	1.7	2.0	3.4	3.3	3.1
CI Cigna Group	4.9992 of 5 stars	4.5	3.0	3.3	4.2	2.9	1.7	3.8
JNJ Johnson & Johnson	4.7778 of 5 stars	2.3	4.0	4.2	3.9	3.0	1.7	1.9
MRK Merck & Co., Inc.	4.9992 of 5 stars	3.2	4.0	5.0	4.2	3.4	2.5	3.8
NWSA News	4.0953 of 5 stars	3.6	3.0	1.7	0.0	2.8	2.5	1.9
PFE Pfizer	4.9685 of 5 stars	3.2	3.0	4.2	4.5	2.7	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AIG American International Group	2.61	Moderate Buy	$88.12	7.79% Upside
CI Cigna Group	3.00	Buy	$380.39	25.66% Upside
JNJ Johnson & Johnson	2.55	Moderate Buy	$171.00	9.01% Upside
MRK Merck & Co., Inc.	2.43	Hold	$108.69	30.40% Upside
NWSA News	3.14	Buy	$39.20	32.70% Upside
PFE Pfizer	2.45	Hold	$28.55	11.31% Upside

Current Analyst Ratings Breakdown

Latest JNJ, PFE, MRK, AIG, NWSA, and CI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/10/2025	JNJ Johnson & Johnson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underperform ➝ Underperform
7/10/2025	JNJ Johnson & Johnson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$169.00 ➝ $171.00
7/10/2025	MRK Merck & Co., Inc.	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$99.00 ➝ $98.00
6/26/2025	CI Cigna Group	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$371.00
6/23/2025	CI Cigna Group	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/5/2025	JNJ Johnson & Johnson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$181.00
6/3/2025	CI Cigna Group	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$371.00
6/2/2025	CI Cigna Group	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$382.00 ➝ $385.00
5/29/2025	PFE Pfizer	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$28.00 ➝ $25.00
5/23/2025	CI Cigna Group	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$388.00
5/21/2025	PFE Pfizer	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $33.00

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AIG American International Group	$27.25B	1.73	$11.15 per share	7.33	$70.20 per share	1.16
CI Cigna Group	$247.12B	0.33	$36.96 per share	8.19	$148.27 per share	2.04
JNJ Johnson & Johnson	$89.33B	4.23	$13.17 per share	11.91	$29.69 per share	5.28
MRK Merck & Co., Inc.	$64.17B	3.26	$9.43 per share	8.84	$18.33 per share	4.55
NWSA News	$10.09B	1.66	$2.01 per share	14.71	$15.83 per share	1.87
PFE Pfizer	$62.46B	2.33	$4.38 per share	5.86	$15.62 per share	1.64

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AIG American International Group	-$1.40B	-$2.66	N/A	10.71	0.91	-7.05%	7.13%	1.87%	8/6/2025 (Confirmed)
CI Cigna Group	$3.43B	$18.06	16.76	9.16	0.92	1.97%	18.63%	4.97%	7/31/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$8.99	17.45	14.17	2.36	24.42%	33.46%	13.30%	7/16/2025 (Estimated)
MRK Merck & Co., Inc.	$17.12B	$6.87	12.13	8.42	0.87	27.27%	43.23%	17.11%	7/29/2025 (Estimated)
NWSA News	$266M	$0.86	34.35	26.38	N/A	5.18%	5.64%	3.09%	8/6/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	18.59	8.47	0.93	12.62%	20.33%	8.53%	8/5/2025 (Estimated)

Latest JNJ, PFE, MRK, AIG, NWSA, and CI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	AIG American International Group	$1.66	N/A	N/A	N/A	$6.81 billion	N/A
8/5/2025	Q2 2025	PFE Pfizer	$0.57	N/A	N/A	N/A	$13.43 billion	N/A
7/31/2025	Q2 2025	CI Cigna Group	$7.14	N/A	N/A	N/A	$62.61 billion	N/A
7/29/2025	Q2 2025	MRK Merck & Co., Inc.	$2.03	N/A	N/A	N/A	$15.92 billion	N/A
7/16/2025	Q2 2025	JNJ Johnson & Johnson	$2.65	N/A	N/A	N/A	$22.85 billion	N/A
5/8/2025	Q3 2025	NWSA News	$0.19	$0.17	-$0.02	$0.18	$2.00 billion	$2.01 billion
5/2/2025	Q1 2025	CI Cigna Group	$6.35	$6.74	+$0.39	$4.85	$60.39 billion	$65.45 billion
5/1/2025	Q1 2025	AIG American International Group	$1.04	$1.17	+$0.13	$1.16	$6.89 billion	$6.77 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/24/2025	Q1 2025	MRK Merck & Co., Inc.	$2.16	$2.22	+$0.06	$2.01	$15.59 billion	$15.53 billion
4/15/2025	Q1 2025	JNJ Johnson & Johnson	$2.59	$2.77	+$0.18	$4.54	$21.65 billion	$21.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AIG American International Group	$1.80	2.20%	N/A	N/A	3 Years
CI Cigna Group	$6.04	2.00%	N/A	33.44%	5 Years
JNJ Johnson & Johnson	$5.20	3.31%	N/A	57.84%	64 Years
MRK Merck & Co., Inc.	$3.24	3.89%	N/A	47.16%	14 Years
NWSA News	$0.20	0.68%	N/A	23.26%	N/A
PFE Pfizer	$1.72	6.71%	N/A	124.64%	16 Years

Latest JNJ, PFE, MRK, AIG, NWSA, and CI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
5/27/2025	MRK Merck & Co., Inc.	quarterly	$0.81	4.18%	6/16/2025	6/16/2025	7/8/2025
5/2/2025	AIG American International Group	quarterly	$0.45	2.1%	6/13/2025	6/13/2025	6/27/2025
4/23/2025	CI Cigna Group	quarterly	$1.51	1.79%	6/3/2025	6/3/2025	6/18/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025
4/15/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.37%	5/27/2025	5/27/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AIG American International Group	0.21	0.64	0.64
CI Cigna Group	0.65	0.72	0.72
JNJ Johnson & Johnson	0.49	1.26	1.03
MRK Merck & Co., Inc.	0.69	1.41	1.16
NWSA News	0.21	1.68	1.60
PFE Pfizer	0.64	1.26	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AIG American International Group	90.60%
CI Cigna Group	86.99%
JNJ Johnson & Johnson	69.55%
MRK Merck & Co., Inc.	76.07%
NWSA News	66.97%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
AIG American International Group	0.50%
CI Cigna Group	0.70%
JNJ Johnson & Johnson	0.16%
MRK Merck & Co., Inc.	0.13%
NWSA News	13.60%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AIG American International Group	22,200	576.33 million	573.45 million	Optionable
CI Cigna Group	73,500	267.14 million	265.27 million	Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable
MRK Merck & Co., Inc.	75,000	2.51 billion	2.51 billion	Optionable
NWSA News	23,900	566.11 million	489.12 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

JNJ, PFE, MRK, AIG, NWSA, and CI Headlines

Recent News About These Companies

“Nobody Ever Went Broke Taking a Profit” – Grab The Highest-Yielding S&P 500 Stocks Right Now

4 hours ago | 247wallst.com

Pfizer (NYSE:PFE) Stock Price Down 1.3% - Here's Why

4 hours ago | marketbeat.com

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

4 hours ago | zacks.com

Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Atopic Dermatitis

5 hours ago | theglobeandmail.com

Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema

5 hours ago | tipranks.com

Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Potential Game-Changer

5 hours ago | tipranks.com

Pfizer’s Promising Migraine Study in Adolescents: What Investors Should Know

5 hours ago | tipranks.com

Pfizer’s Latest Study on HER2-positive Breast Cancer Treatment: Key Insights for Investors

5 hours ago | tipranks.com

Pfizer’s Inclacumab Study: A Potential Game-Changer for Sickle Cell Disease

5 hours ago | tipranks.com

Pfizer’s New Study on COVID-19 Vaccine Effectiveness: What Investors Need to Know

5 hours ago | tipranks.com

Pfizer’s New Phase 1 Study: A Potential Game-Changer in Cancer Treatment?

5 hours ago | tipranks.com

Pfizer’s Study on Rimegepant and Pregnancy: What Investors Need to Know

5 hours ago | tipranks.com

Pfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for Infant RSV Protection

5 hours ago | tipranks.com

Pfizer’s EPIC-Peds Study: New Insights into Pediatric COVID-19 Treatment

5 hours ago | tipranks.com

Pfizer’s Palbociclib Study: Real-World Insights on Advanced Breast Cancer Treatment

5 hours ago | tipranks.com

Pfizer’s Tukysa Study: A Closer Look at Safety and Efficacy in South Korea

5 hours ago | tipranks.com

Pfizer Inc. (NYSE:PFE) Stock Position Lifted by Callahan Advisors LLC

July 11 at 8:40 AM | marketbeat.com

Barry Investment Advisors LLC Decreases Position in Pfizer Inc. (NYSE:PFE)

July 11 at 8:24 AM | marketbeat.com

SteelPeak Wealth LLC Has $5.60 Million Stock Holdings in Pfizer Inc. (NYSE:PFE)

July 11 at 8:23 AM | marketbeat.com

Croban Purchases New Position in Pfizer Inc. (NYSE:PFE)

July 11 at 7:30 AM | marketbeat.com

Bernstein Sticks to Its Hold Rating for Pfizer (PFE)

July 10 at 10:50 PM | theglobeandmail.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
D-Wave Goes International With South Korea Partnership
By Nathan Reiff | June 23, 2025
View D-Wave Goes International With South Korea Partnership
Top 5 Undervalued Dividend Stocks With Strong Payout Potential
By Ryan Hasson | July 7, 2025
View Top 5 Undervalued Dividend Stocks With Strong Payout Potential

JNJ, PFE, MRK, AIG, NWSA, and CI Company Descriptions

American International Group NYSE:AIG

$81.75 -0.71 (-0.86%)

Closing price 03:58 PM Eastern

Extended Trading

$83.50 +1.75 (+2.14%)

As of 04:58 PM Eastern

American International Group, Inc. offers insurance products for commercial, institutional, and individual customers in North America and internationally. It operates through three segments: General Insurance, Life and Retirement, and Other Operations. The General Insurance segment provides commercial and industrial property insurance, including business interruption and package insurance that cover exposure to made and natural disasters; general liability, environmental, commercial automobile liability, workers' compensation, excess casualty, and crisis management insurance products; and professional liability insurance. This segment offers marine, energy-related property insurance, aviation, political risk, trade credit, trade finance, and portfolio solutions, as well as operates reinsurance business; voluntary and sponsor-paid personal accident, and supplemental health products; and personal auto and personal property insurance. Its Life and Retirement segment offers individual retirement products, including variable, fixed index, and fixed annuities, as well as retail mutual funds; group retirement products comprising record-keeping, plan administrative and compliance services, financial planning, and advisory solutions; life insurance, including term and universal life insurance; and institutional markets products, which includes wrap products, structured settlement, pension risk transfer annuities, corporate and bank-owned life insurance, high net worth, and guaranteed investment contract products. It distributes its products through a network of brokers, agents, advisors, banks, and other distributors. The company was founded in 1919 and is headquartered in New York, New York.

Cigna Group NYSE:CI

$302.71 -6.07 (-1.97%)

Closing price 03:58 PM Eastern

Extended Trading

$306.07 +3.36 (+1.11%)

As of 04:58 PM Eastern

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Johnson & Johnson NYSE:JNJ

$156.87 -0.82 (-0.52%)

Closing price 03:59 PM Eastern

Extended Trading

$156.52 -0.34 (-0.22%)

As of 05:05 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Merck & Co., Inc. NYSE:MRK

$83.35 -0.67 (-0.80%)

Closing price 03:59 PM Eastern

Extended Trading

$83.70 +0.35 (+0.42%)

As of 05:04 PM Eastern

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

News NASDAQ:NWSA

$29.54 -0.12 (-0.40%)

Closing price 04:00 PM Eastern

Extended Trading

$29.54 0.00 (0.00%)

As of 04:50 PM Eastern

News Corporation, a media and information services company, creates and distributes authoritative and engaging content, and other products and services for consumers and businesses worldwide. It operates through six segments: Digital Real Estate Services, Subscription Video Services, Dow Jones, Book Publishing, News Media, and Other. The company distributes content and data products, including The Wall Street Journal, Barron's, MarketWatch, Investor's Business Daily, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, and Dow Jones Energy through various media channels, such as newspapers, newswires, websites, mobile apps, newsletters, magazines, proprietary databases, live journalism, video, and podcasts. It also owns and operates Monday to Friday, Saturday and Sunday, weekly, and bi-weekly newspapers comprising The Australian, The Weekend Australian, The Daily Telegraph, The Sunday Telegraph, Herald Sun, Sunday Herald Sun, The Courier Mail, The Sunday Mail, The Advertiser, Sunday Mail, The Sun, The Sun on Sunday, The Times, The Sunday Times, and New York Post, as well as digital mastheads and other websites. In addition, the company publishes general fiction, nonfiction, children's, and religious books; provides sports, entertainment, and news services to pay-TV and streaming subscribers, and other commercial licensees through satellite and internet distribution; and broadcasts rights to live sporting events. Further, it offers property and property-related advertising and services on its websites and mobile applications; digital real estate services; and financial services. News Corporation was founded in 2012 and is headquartered in New York, New York.

Pfizer NYSE:PFE

$25.65 -0.13 (-0.50%)

Closing price 03:59 PM Eastern

Extended Trading

$25.64 0.00 (-0.02%)

As of 05:04 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest JNJ, PFE, MRK, AIG, NWSA, and CI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest JNJ, PFE, MRK, AIG, NWSA, and CI Earnings

Compare Dividends

Latest JNJ, PFE, MRK, AIG, NWSA, and CI Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

JNJ, PFE, MRK, AIG, NWSA, and CI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

JNJ, PFE, MRK, AIG, NWSA, and CI Company Descriptions

American International Group NYSE:AIG

Cigna Group NYSE:CI

Johnson & Johnson NYSE:JNJ

Merck & Co., Inc. NYSE:MRK

News NASDAQ:NWSA

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools